SeaStar Medical Holding Corp
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
ICU$1.88-2.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Financial Statements (Unaudited)Condensed Consolidated Balance Sheets (June 2024 Unaudited)
Item 1. Condensed Consolidated Financial Statements.
Condensed Consolidated Balance Sheets
| As ofJune 30, 2024 | As ofDecember 31, 2023 | |
|---|---|---|
| (unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash | $1,179 | $176 |
| Prepaid expenses | 1,235 | 2,132 |
| Total current assets | 2,414 | 2,308 |
| Other assets | 1,053 | 1,205 |
| Total assets | $3,467 | $3,513 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current liabilities | ||
| Accounts payable | $4,117 | $4,372 |
| Accrued expenses | 2,258 | 1,523 |
| Upfront payment for license agreement | — | 100 |
| Contract liabilities, current portion | 112 | — |
| Notes payable, net of deferred financing costs | 3,140 | 565 |
| Convertible notes, current portion | — | 4,179 |
| Liability classified warrants | 303 | 2,307 |
| Total current liabilities | 9,930 | 13,046 |
| Notes payable, net of deferred financing costs | — | 4,143 |
| Contract liabilities, net of current portion | 438 | — |
| Convertible notes, net of current portion | — | 194 |
| Total liabilities | 10,368 | 17,383 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' deficit | ||
| Preferred stock - $0.0001 par value per share; 10,000,000 shares authorized at June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023 | — | — |
| Common stock - $0.0001 par value per share; 500,000,000 shares authorized; 3,221,104 and 1,904,611 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | 1 | 1 |
| Additional paid-in capital | 123,765 | 100,863 |
| Accumulated deficit | (130,667) | (114,734) |
| Total stockholders' deficit | (6,901) | (13,870) |
| Total liabilities and stockholders' deficit | $3,467 | $3,513 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.